Argo Biopharma’s first siRNA drug approved for clinical study in China, the United States, and Australia.
Learn MoreArgo Biopharma’s second siRNA drug approved for clinical study in Australia.
Learn MoreArgo Biopharma’s first siRNA drug approved for clinical study in Australia.
Learn MoreArgo Biopharma closed series A financing of 63 million US dollars.
Learn MoreArgo Biopharma closed angel round financing of nearly 5 millon US dollars.
Learn More为了更好的呈现效果,移动端请竖屏浏览